Tirzepatide represents a groundbreaking treatment agent for individuals battling type 2 diabetes. As a dual stimulator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic https://amaanzchj832777.blog2learn.com/88164335/tirzepatide-a-novel-glp-1-and-gip-receptor-agonist